Boston Angel Investors →
Top Entrepreneurs' Advice →
Support Xconomy Detroit →
Incubator Guide →
Managing Director, Mercury Fund
Partner, Morgenthaler Ventures
Chairman, EDventure Holdings
Founder, Windward Associates
Product Manager, Foursquare
Instructor in Pediatrics, Harvard Medical School
Professor of Genetics, Harvard Medical School
CEO, i-Human Patients.
NKT Therapeutics is developing drugs that target a class of immune cells known as natural killer T cells.
Xconomy offers a number of ways to subscribe for free!
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas, Wisconsin and beyond.
© 2007-2013, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Website development support from Andrew Koyfman with design support from Rob Hunter.